Quercetin & AR-V7.: New study below [... - Advanced Prostate...

Advanced Prostate Cancer

21,008 members26,183 posts

Quercetin & AR-V7.

pjoshea13 profile image
10 Replies

New study below [1].

A common form of resistance to Xtandi & Zytiga is the emergence of androgen receptor [AR] splice variant AR-V7, which retains AR functionality but does not need androgen for activation.

"Numerous studies including ours suggest that splicing factors such as hnRNPA1 promote the generation of AR-V7, thus contributing to enzalutamide resistance in prostate cancer cells."

"In the present study, we discovered that quercetin, a naturally occurring polyphenolic compound, reduces the expression of hnRNPA1, and consequently, that of AR-V7. The suppression of AR-V7 by quercetin resensitizes enzalutamide-resistant prostate cancer cells to treatment with enzalutamide."

Seems prudent to use quercetin while on Xtandi or Zytiga, etc.

-Patrick

[1] ncbi.nlm.nih.gov/pubmed/287...

Mol Cancer Ther. 2017 Jul 20. pii: molcanther.0030.2017. doi: 10.1158/1535-7163.MCT-17-0030. [Epub ahead of print]

Quercetin targets hnRNPA1 to overcome enzalutamide resistance in prostate cancer cells.

Tummala R1, Lou W1, Gao AC1, Nadiminty N2.

Author information

1

Department of Urology, University of California Davis.

2

Department of Urology, University of Toledo nagalakshmi.nadiminty@utoledo.edu.

Abstract

Prostate cancer remains dependent on androgen receptor signaling even after castration. Aberrant androgen receptor signaling in castration resistant prostate cancer is mediated by mechanisms such as alterations in the androgen receptor and activation of interacting signaling pathways. Clinical evidence confirms that resistance to the next generation anti-androgen, enzalutamide, may be mediated to a large extent by alternative splicing of the androgen receptor to generate constitutively active splice variants such as AR-V7. The splice variants AR-V7 and Arv567es have been implicated in the resistance to not only enzalutamide, but also to abiraterone and other conventional therapeutics such as taxanes. Numerous studies including ours suggest that splicing factors such as hnRNPA1 promote the generation of AR-V7, thus contributing to enzalutamide resistance in prostate cancer cells. In the present study, we discovered that quercetin, a naturally occurring polyphenolic compound, reduces the expression of hnRNPA1, and consequently, that of AR-V7. The suppression of AR-V7 by quercetin resensitizes enzalutamide-resistant prostate cancer cells to treatment with enzalutamide. Our results indicate that quercetin downregulates hnRNPA1 expression, downregulates the expression of AR-V7, antagonizes androgen receptor signaling, and resensitizes enzalutamide-resistant prostate cancer cells to enzalutamide treatment in vivo in mouse xenografts. These findings demonstrate that suppressing the alternative splicing of the androgen receptor may have important implications in overcoming the resistance to next-generation anti-androgen therapy.

Copyright ©2017, American Association for Cancer Research.

PMID: 28729398 DOI: 10.1158/1535-7163.MCT-17-0030

Written by
pjoshea13 profile image
pjoshea13
To view profiles and participate in discussions please or .
Read more about...
10 Replies
Neal-Snyder profile image
Neal-Snyder

Hi Patrick,

Thanks very much for this. Is there any indication of what might be an appropriate dose? Thanks again.

Neal

pjoshea13 profile image
pjoshea13 in reply to Neal-Snyder

Hi Neal,

I seem to have neglected quercetin in my "Foods/Supplements-Vitamins:" series.

I don't recall that bioavailability is an issue, or side effects. I would use a high dose in the context of my post. What might that be? 2-3 high-strength caps 3 times daily? A guess. I will try to do better.

-Patrick

Dan59 profile image
Dan59

Thank You Patrick, I am going to get some quercetin and start taking it in anticipation of taking a chemo break and going back on xtandi. Nothing I would like better than to reuse zytiga and xtandi.

It would seem prudent for those on xtandi and zytiga to be supplementing with quercetin

Dan

Thinus profile image
Thinus

Thanks for the info, already using Quercitin in Combination with Green Tea Extract (concetrated). Not yet on Casodex or Xtandi, just Lucrin.

Dan59 profile image
Dan59

Thanks Joel, I found a study from pub med on niclosamide overcoming xtandi resistance , I have printed it and will bring it to my MO this week.

Dan

ctarleton profile image
ctarleton in reply to Dan59

This is interesting, too.

www3.epa.gov/pesticides/che...

pjoshea13 profile image
pjoshea13 in reply to ctarleton

Scott Pruitt wouldn't let me in. -Patrick

GeorgeGlass profile image
GeorgeGlass in reply to ctarleton

what was the conclusion of this article? I couldn't open it.

ctarleton profile image
ctarleton in reply to GeorgeGlass

It was a 9 page US EPA Pesticides Fact Sheet for Niclosamide, document # EPA-738-F99-013, dating from 1999, when Niclosamide had been used for poisoning lampreys and snails in the Great Lakes area. Impacts on humans and water quality were also mentioned.

www3.epa.gov/pesticides/che...

GeorgeGlass profile image
GeorgeGlass in reply to ctarleton

oh ok, thanks. Pesticides just about everywhere and very little being done to stop it:(

You may also like...

Quercetin targets hnRNPA1 to overcome enzalutamide resistance in prostate cancer cells

\\"The suppression of AR-V7 by quercetin resensitizes enzalutamide-resistant prostate cancer cells...

AR-V7 - CTC's - Risk of Death

it-for-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc.html

overall survival time with Ar-v7

without it, or if it doesn't work on the individual's cancer, seven months. We are looking to be...

Doctor refuses to test for AR-V7

since hubby progressed on both Abiraterone and Xtandi the test is useless. I mentioned re-challenge...

\"New Normal\" AR-v7 Questions

reports, PSA declining to immeasurable, \\"dormant\\" cancer, feeling like you can finally breathe...